You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《半日速报》恒指半日收报26,669点 跌21点 中生制药跌逾4% 新东方在线、锦欣生殖、中国东方教育、波司登、方达控股创新高
阿思达克 09-09 12:05

恒指半日收26,669点,跌21点或0.1%。国指跌4点或0.0%,报10,425点。活跃重磅股表现:

建行(00939.HK) 收6.07元,上升0.7%;

腾讯(00700.HK) 收341.2元,下跌0.6%;

工行(01398.HK) 收5.2元,上升0.4%;

汇控(00005.HK) 收58.1元,上升0.3%;

友邦(01299.HK) 收79.2元,下跌0.2%;

平安(02318.HK) 收93.9元,上升0.1%;

异动恒指及国指成份股:

中生制药(01177.HK) 收10.92元,下跌4.4%;

吉利(00175.HK) 收13.28元,上升4.1%;

中石油(00857.HK) 收4.13元,上升3.5%;异动综合中小型股:

南方能源(01573.HK) 收0.95元,上升28.4%;

港华燃气(01083.HK) 收6.27元,上升15%;

新东方在线(01797.HK) 收13.98元,上升12%,创新高;

锦欣生殖(01951.HK) 收11.84元,上升9.6%,创新高;

中国东方教育(00667.HK) 收14.6元,上升5%,创新高;

波司登(03998.HK) 收3.13元,上升4.3%,创新高;

方达控股(01521.HK) 收4.24元,上升3.7%,创新高;

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account